U.K. biopharma giant AstraZeneca tops the list of the most innovative biopharma company’s, according to a recently published list compiled by IDEA Pharma. The list, based on the Pharmaceutical Invention Index and debuting this year, has Celgene, Eli Lilly, Novartis Abbvie and Vertex (tie) rounding out the top 5. The list was created by evaluating four factors; proportion of pipeline to marketed drugs, number of trials investigating novel agents, proportion of ‘novel’ regulatory designations and assessment of the company’s R&D investments. Surprisingly, neither Pfizer nor Roche, both recognized innovators, appear in the top 10. Learn More